Edition:
United Kingdom

Aptargroup Inc (ATR.N)

ATR.N on New York Stock Exchange

94.64USD
20 Jun 2018
Change (% chg)

$0.39 (+0.41%)
Prev Close
$94.25
Open
$94.01
Day's High
$94.86
Day's Low
$94.00
Volume
75,523
Avg. Vol
90,182
52-wk High
$96.39
52-wk Low
$80.05

Summary

Name Age Since Current Position

George Fotiades

64 2018 Chairman of the Board

Stephan Tanda

52 2017 President, Chief Executive Officer, Director

Robert Kuhn

55 2011 Chief Financial Officer, Executive Vice President, Secretary

Salim Haffar

44 2014 President - Aptar Pharma

Eldon Schaffer

52 2016 President - Aptar Beauty and Home

Gael Touya

48 2016 President, Aptar Food and Beverage

Ursula Saint-Leger

54 2010 Vice President - Human Resources

Stephen Hagge

66 2017 Director

Alain Chevassus

73 2001 Independent Director

Andreas Kramvis

65 2014 Independent Director

Giovanna Monnas

62 2010 Independent Director

Maritza Montiel

66 2015 Independent Director

Craig Owens

63 2018 Independent Director

Joanne Smith

57 1999 Independent Director

Jesse Wu

61 2018 Independent Director

Ralf Wunderlich

51 2009 Independent Director

Biographies

Name Description

George Fotiades

Mr. George L. Fotiades has been appointed Chairman of the Board of the Company. He has been Operating Partner at Five Arrows Capital Partners (U.S. private equity business of Rothschild Merchant Banking) since April 2017. From 2007 through April 2017, he was Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing). He is a director of the following NYSE-listed companies: Prologis, Inc. (integrated distribution facilities and services) and Cantel Medical Corp. (infection prevention and control products). Effective at the annual meeting, Mr. Fotiades will assume the role of Chairman of the Board of Aptar. The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of Aptar in part due to his experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert's Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb's Consumer Products, Japan division. The Board also considered his present and past board level experience with global organizations.

Stephan Tanda

Mr. Stephan B. Tanda serves as President, Chief Executive Officer, Director of the Company, He became President and Chief Executive Officer of Aptar on February 1, 2017. Prior to this, Mr. Tanda served from 2007 until 2017 as an Executive Managing Board Director at Royal DSM NV (leading global supplier of ingredients and material solutions for the food, dietary supplement, personal care, medical device, automotive, paint, electronic and bio-material markets), where he was responsible for DSM's Nutrition and Pharma activities, as well as DSM's presence in the Americas and various corporate duties. Mr. Tanda was a director of Patheon NV (formerly a NYSE listed company that provided pharmaceutical development and manufacturing services) from March 2016 until the company was sold to Thermo Fisher Scientific on August 29, 2017. The Board of Directors concluded that Mr. Tanda should serve as a director of Aptar due in part to his role as President and Chief Executive Officer, his extensive global experience leading and building successful business-to-business organizations in several markets currently served by Aptar, as well as his transaction and integration experience.

Robert Kuhn

Mr. Robert W. Kuhn is Chief Financial Officer, Executive Vice President, Secretary of the Company. Mr. Kuhn has been Executive Vice President and Chief Financial Officer since September 2008. Mr. Kuhn has been Secretary since June 2011. Prior to this, Mr. Kuhn was Vice President Financial Reporting from 2000 to 2008.

Salim Haffar

Mr. Salim Haffar is no longer a President - Aptar Pharma of the Company effective September 1, 2018. He has been President of Aptar Pharma since January 2014. From 2012 to 2013 Mr. Haffar worked with Capsugel, a leading pharmaceutical supplier of gelatin capsules for the oral drug delivery industry. From 2010 to 2012, he was President of Aptar Pharma’s Prescription division.

Eldon Schaffer

Mr. Eldon Schaffer serves as President of Aptar Beauty and Home of the Company. Prior to this, Mr. Schaffer was President of Aptar Food and Beverage from 2012 to 2015 and President of Aptar Beauty and Home North America from 2010 to 2011.

Gael Touya

Mr. Gael Touya is re-designated as President - Aptar Pharma of the Company effective September 1, 2018. He is no longer serves as President of Aptar Food and Beverage of the Company effective from September 2018. Prior to this, Mr. Touya was President of Aptar Food and Beverage Europe from 2012 to 2015 and Business Development Vice President Skin Care and Color Cosmetics from 2010 to 2011.

Ursula Saint-Leger

Ms. Ursula Saint-Leger serves as Vice President of Human Resources of the Company effective, February 2017. Prior to joining Aptar Group in 2010, Ms. Saint-Leger was Sr. Group Vice President Human Resources at TAQA (industrialization and energy services) from 2009 to 2010 and was Senior Vice President Human Resources at Umicore (materials technology) from 2004 to 2009.

Stephen Hagge

Mr. Stephen J. Hagge serves as Director of the AptarGroup Inc. He is was the President and Chief Executive Officer of Aptar from 2011 until February 1, 2017. From February 1, 2017 through March 31, 2017, Mr. Hagge served as Special Advisor to the Chief Executive Officer of Aptar. Mr. Hagge is a director of CF Industries Holdings, Inc. (a NYSE-listed nitrogen fertilizer manufacturer). The Board of Directors concluded that Mr. Hagge should continue to serve as a director of Aptar in part due to his previous role as President and Chief Executive Officer, his deep understanding of Aptar's business, as demonstrated by his more than 30 years as an executive of Aptar and its predecessor company, his knowledge of and background in the global dispensing systems and consumer packaging industry and his financial and senior management experience.

Alain Chevassus

Mr. Alain Chevassus is has been President of COSFIBEL Group (flexible plastic packaging) since 2000. The Board of Directors concluded that Mr. Chevassus should continue to serve as a director of Aptar in part due to his executive role as President of COSFIBEL Group, his knowledge of and background in the global packaging, merchandising solutions and cosmetics industries, particularly with respect to product categories that are important to Aptar, and his global financial and senior management experience.

Andreas Kramvis

Mr. Andreas C. Kramvis is an operating partner at AEA Investors (a private equity firm). Mr. Kramvis was Vice Chairman of Honeywell International (a multi-industry company with presence in Aerospace, Automation and Controls, Chemicals and Automotive Industries) from April 2014 to February 2017. From 2008 to 2014, Mr. Kramvis was President and Chief Executive Officer of the Honeywell Performance Materials and Technologies group (a developer of processes and chemicals for oil refining, petrochemicals and a variety of high-purity, high-quality performance chemicals and materials). He is a director of Axalta Coating Systems Ltd. (a NYSE-listed developer, manufacturer and seller of liquid and powder coatings). The Board of Directors concluded that Mr. Kramvis should continue to serve as a director of Aptar in part due to his experience from holding senior executive positions at Honeywell, as well as his management of several companies with global businesses across five different industries. This experience has also led the Board to determine that Mr. Kramvis is an "audit committee financial expert" as defined by the SEC.

Giovanna Monnas

Ms. Giovanna Kampouri Monnas is an Independent Director of the Company. is an independent consultant and serves on the boards of several global companies. Ms. Kampouri Monnas is a member of the supervisory board and Chairman of the Compensation Committee of Randstad Holding NV (a Euronext-listed provider of human resource services based in Amsterdam), as well as a director of Puig S.L. (fragrances, beauty and fashion products company based in Spain) and Imerys S.A. (a Euronext-listed producer of industrial minerals, based in France). The Board of Directors concluded that Ms. Kampouri Monnas should continue to serve as a director of Aptar in part due to her experience from previously holding senior executive positions at leading global consumer marketing companies including Joh. Benckiser GmbH (consumer products company) and The Procter & Gamble Company (consumer products company), her knowledge of and background in the fragrance and cosmetic markets, which are particularly important to Aptar, and her global marketing and senior management experience.

Maritza Montiel

Ms. Maritza Gomez Montiel is an Independent Director of the Company. She served as Deputy Chief Executive Officer and Vice Chairman of Deloitte LLP from 2011 through her retirement in May 2014. During Ms. Montiel's tenure at Deloitte, she was the Advisory Partner for many engagements in which Deloitte was the principal auditor. Ms. Montiel has over 30 years of experience in leading and performing audits of various entities. Ms. Montiel is a director of McCormick & Company, Inc. (a NYSE-listed spice, herb and flavoring manufacturer) and Royal Caribbean Cruises Ltd. (a NYSE-listed global cruise company).

Craig Owens

Mr. Craig Owens has been appointed Independent Director of the Company. He is the Chief Financial Officer and Chief Administrative Officer of Campbell Soup Company (global producer and seller of canned soups and related products) from 2008 through 2014. In addition, he was the Chairman of the company's Operating Committee. Mr. Owens is a director of J. C. Penney Company, Inc. (a NYSE-listed U.S. department store chain) and Dean Foods Company (a NYSE-listed U.S. food and beverage company). The Board of Directors concluded that Mr. Owens should continue to serve as a director of Aptar due to his extensive experience in the consumer food and beverage industries, which is particularly relevant for Aptar's Food + Beverage business, as well as his significant expertise in financial reporting, accounting, corporate finance and capital markets.

Joanne Smith

Dr. Joanne C. Smith, M.D. is an Independent Director of the Company. a physician at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago or "RIC") and became the AbilityLab's President and Chief Executive Officer in 2006. Dr. Smith is a director of Performance Health, Inc. (rehabilitation and wellness products manufacturer). From 2003 to 2015, Dr. Smith was a director of Hill-Rom, Inc. (a NYSE-listed healthcare and medical technology, formerly Hillenbrand Industries). The Board of Directors concluded that Dr. Smith should continue to serve as a director of Aptar in part due to her executive background as President and Chief Executive Officer of a leading research and healthcare rehabilitation organization, her public company director experience, her knowledge of and background in the healthcare and medical technology industry, which is particularly relevant for Aptar's Pharma business, and her strategic planning, operations and senior management experience.

Jesse Wu

Mr. Jesse Wu has been appointed Independent Director of the Company . He is an advisor to private equity firms. From 2003 through 2016, Mr. Wu held senior leadership roles at Johnson & Johnson (multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company) including Chairman of Johnson & Johnson China and Worldwide Chairman of the company's Consumer Healthcare Division. Mr. Wu is a director of The a2Milk Company Limited (an ASX- and NZX-listed company that commercializes intellectual property relating to a2 milk and related products), Shanghai Kehua Bio-Engineering Co. Ltd. (a SZSE-listed manufacturer of in vitro diagnostic products) and Li-Ning Company Limited (a SEHK-listed manufacturer of athletic shoes and sporting goods).

Ralf Wunderlich

Mr. Ralf Klaus Wunderlich is an Independent Director of the Company. He is an advisor and operating partner to several private equity companies. He was a member of Amcor Limited's Global Executive Team and was President of the business group Amcor Flexibles Asia Pacific (packaging solutions) from 2010 to 2016. Mr. Wunderlich was a director of AMVIG Holdings Limited (a SEHK-listed cigarette packaging and printing company) from 2010 to 2015. Mr. Wunderlich is a director of Essentra PLC (a LSE-listed supplier of plastic and fibre products).

Basic Compensation

Name Fiscal Year Total

George Fotiades

231,507

Stephan Tanda

6,293,340

Robert Kuhn

3,658,460

Salim Haffar

3,291,880

Eldon Schaffer

3,310,000

Gael Touya

2,498,970

Ursula Saint-Leger

--

Stephen Hagge

886,262

Alain Chevassus

212,007

Andreas Kramvis

222,007

Giovanna Monnas

212,007

Maritza Montiel

231,007

Craig Owens

--

Joanne Smith

222,007

Jesse Wu

--

Ralf Wunderlich

212,007
As Of  31 Dec 2017

Options Compensation